Public Alert No.31/2023 – Important Safety Communication on Abbott Diagnostics Medical Device
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying Healthcare providers that Abbott has identified that some lots of m-PIMA HIV-1/2 VL do not meet performance claims for HIV-1 group O and HIV-1 group M and N throughout the claimed shelf life. This was discovered through an internal stability monitoring program. […]